Director/PDMR Shareholding

RNS Number : 4391I

GlaxoSmithKline PLC

30 August 2016

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr N Hirons
b)	Position/status	SVP, Global Ethics & Compliance
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ISIN: GB0009252882
b)	Nature of the transaction	Following the vesting on 26 August 2016 of an award made on 24 September 2014 under the GlaxoSmithKline Deferred Investment Award Plan, Mr N Hirons will receive a cash payment of £288,000.11 less applicable tax withholding in respect of 17,489 notional ordinary shares.
c)	Price(s) and volume(s)	Price(s) Volume(s) £16.4675 17,489 notional ordinary shares.
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-08-26
f)	Place of the transaction	n/a

 

END

 

 

DSHFBLFXQVFXBBZ